Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 28, 2020; 26(28): 4170-4181
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4170
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4170
Table 3 Analysis of clinical response for epigastric pain in a full analysis set, n (%)
| Placebo group, n = 120 | BLWTG group, n = 118 | P value | |
| Total | < 0.0001 | ||
| Responsive | 34 (28.33) | 101 (85.59) | |
| Not responsive | 86 (71.67) | 17 (14.41) | |
| Baseline VAS score, 4 ≤ VAS < 7 | |||
| Responsive | 27( 30.34) | 77 (88.51) | < 0.0001 |
| Not responsive | 62 (69.66) | 10 (11.49) | |
| Baseline VAS score, 7 ≤ VAS ≤ 10 | |||
| Responsive | 7 (22.58) | 24 (77.42) | < 0.0001 |
| Not responsive | 24 (77.42) | 7 (22.58) |
- Citation: Wen YD, Lu F, Zhao YP, Wang P, Yang Q, Li JX, Li HZ, Chi LL, Zhou ZH, Tang YP, Xu JK, Zhao Y, Tang XD. Epigastric pain syndrome: What can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules. World J Gastroenterol 2020; 26(28): 4170-4181
- URL: https://www.wjgnet.com/1007-9327/full/v26/i28/4170.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i28.4170